These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26203609)

  • 21. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
    O'Donnell DE
    Proc Am Thorac Soc; 2006 Apr; 3(2):180-4. PubMed ID: 16565429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indacaterol add-on therapy improves lung function, exercise capacity and life quality of COPD patients.
    Mroz RM; Minarowski L; Chyczewska E
    Adv Exp Med Biol; 2013; 756():23-8. PubMed ID: 22836615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nebulized morphine for terminal dyspnea.
    Westphal CG; Campbell ML
    Am J Nurs; 2002 May; Suppl():11-5. PubMed ID: 12006868
    [No Abstract]   [Full Text] [Related]  

  • 24. Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease.
    Smallwood N; Gaffney N; Gorelik A; Irving L; Le B; Philip J
    Intern Med J; 2017 Sep; 47(9):1050-1056. PubMed ID: 28585274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
    Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
    Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD.
    Berton DC; Reis M; Siqueira AC; Barroco AC; Takara LS; Bravo DM; Andreoni S; Neder JA
    Respir Med; 2010 Sep; 104(9):1288-96. PubMed ID: 20580216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD.
    Worth H; Förster K; Eriksson G; Nihlén U; Peterson S; Magnussen H
    Respir Med; 2010 Oct; 104(10):1450-9. PubMed ID: 20692140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebulized morphine for relief of dyspnea due to chronic lung disease.
    Brown SJ; Eichner SF; Jones JR
    Ann Pharmacother; 2005 Jun; 39(6):1088-92. PubMed ID: 15840735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palliation of dyspnoea in advanced COPD: revisiting a role for opioids.
    Rocker G; Horton R; Currow D; Goodridge D; Young J; Booth S
    Thorax; 2009 Oct; 64(10):910-5. PubMed ID: 19786716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: a pilot study.
    Pasqua F; Biscione G; Crigna G; Auciello L; Cazzola M
    Respir Med; 2010 Mar; 104(3):412-7. PubMed ID: 19892540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease.
    Gagnon P; Bussières JS; Ribeiro F; Gagnon SL; Saey D; Gagné N; Provencher S; Maltais F
    Am J Respir Crit Care Med; 2012 Oct; 186(7):606-15. PubMed ID: 22822019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial.
    Ahmadi Z; Sandberg J; Shannon-Honson A; Vandersman Z; Currow DC; Ekström M
    Eur Respir J; 2018 Sep; 52(3):. PubMed ID: 30002106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'INSPIRED' approaches to better care for patients with advanced COPD.
    Rocker GM; Cook D
    Clin Invest Med; 2013 Jun; 36(3):E114-20. PubMed ID: 23739664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heliox in chronic obstructive pulmonary disease: lightening the airflow.
    Wedzicha JA
    Am J Respir Crit Care Med; 2006 Apr; 173(8):825-6. PubMed ID: 16601127
    [No Abstract]   [Full Text] [Related]  

  • 35. Opioid-induced neurotoxicity.
    Gallagher R
    Can Fam Physician; 2007 Mar; 53(3):426-7. PubMed ID: 17872676
    [No Abstract]   [Full Text] [Related]  

  • 36. The Link between Reduced Inspiratory Capacity and Exercise Intolerance in Chronic Obstructive Pulmonary Disease.
    O'Donnell DE; Elbehairy AF; Webb KA; Neder JA;
    Ann Am Thorac Soc; 2017 Jul; 14(Supplement_1):S30-S39. PubMed ID: 28398073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. To Improve COPD Care: A New Instrument Is Needed to Assess Dyspnea.
    Mahler DA; Sethi S
    Chest; 2018 Aug; 154(2):235-237. PubMed ID: 30080497
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable.
    O'Donnell DE; Banzett RB; Carrieri-Kohlman V; Casaburi R; Davenport PW; Gandevia SC; Gelb AF; Mahler DA; Webb KA
    Proc Am Thorac Soc; 2007 May; 4(2):145-68. PubMed ID: 17494725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study.
    Verberkt CA; van den Beuken-van Everdingen MH; Franssen FM; Dirksen CD; Schols JM; Wouters EF; Janssen DJ
    Contemp Clin Trials; 2016 Mar; 47():228-34. PubMed ID: 26825021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Opioids for refractory dyspnoea in palliation].
    Aabom B; Bendstrup E; Sjøgren P; Løkke A; Shaker B; Wilcke T; Jespersen BA; Hilberg O; Marsaa K
    Ugeskr Laeger; 2020 Sep; 182(40):. PubMed ID: 33000737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.